Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Oct. 02, 2021	Oct. 03, 2020
Cash flows from operating activities
Income from continuing operations	$ 540	$ 73
Non-cash items:
Depreciation and amortization	285	283
Gain on business disposition	(17)	0
Deferred income taxes	7	(31)
Asset impairments and TRU inventory charge	11	111
Other, net	74	81
Changes in assets and liabilities:
Accounts receivable, net	8	59
Inventories	(164)	(258)
Other assets	(11)	114
Accounts payable	1	(267)
Other liabilities	323	60
Income taxes, net	26	(4)
Pension, net	(62)	(11)
Captive finance receivables, net	152	(25)
Other operating activities, net	1	15
Net cash provided by operating activities of continuing operations	1,174	200
Net cash used in operating activities of discontinued operations	(1)	(1)
Net cash provided by operating activities	1,173	199
Cash flows from investing activities
Capital expenditures	(204)	(151)
Net proceeds from business disposition	38	0
Proceeds from an insurance recovery and sale of property, plant and equipment	3	25
Net proceeds from corporate-owned life insurance policies	0	21
Net cash used in acquisitions	0	(11)
Finance receivables repaid	19	21
Other investing activities, net	17	3
Net cash provided by (used in) investing activities	(127)	(92)
Cash flows from financing activities
Decrease in short-term debt	0	(2)
Net proceeds from long-term debt	0	1,137
Proceeds from borrowings against corporate-owned life insurance policies	0	377
Payment on borrowings against corporate-owned life insurance policies	0	(15)
Principal payments on long-term debt and nonrecourse debt	(615)	(235)
Purchases of Textron common stock	(586)	(54)
Dividends paid	(14)	(14)
Proceeds from options exercised	105	16
Other financing activities, net	(2)	(2)
Net cash provided by (used in) financing activities	(1,112)	1,208
Effect of exchange rate changes on cash and equivalents	(6)	(2)
Net increase (decrease) in cash and equivalents	(72)	1,313
Cash and equivalents at beginning of period	2,254	1,357
Cash and equivalents at end of period	2,182	2,670
Manufacturing group
Cash flows from operating activities
Income from continuing operations	537	67
Non-cash items:
Depreciation and amortization	277	279
Gain on business disposition	(17)	0
Deferred income taxes	9	(30)
Asset impairments and TRU inventory charge	11	111
Other, net	82	74
Changes in assets and liabilities:
Accounts receivable, net	8	59
Inventories	(164)	(258)
Other assets	(10)	114
Accounts payable	1	(267)
Other liabilities	323	66
Income taxes, net	16	1
Pension, net	(62)	(11)
Other operating activities, net	1	15
Net cash provided by operating activities of continuing operations	1,012	220
Net cash used in operating activities of discontinued operations	(1)	(1)
Net cash provided by operating activities	1,011	219
Cash flows from investing activities
Capital expenditures	(204)	(151)
Net proceeds from business disposition	38	0
Proceeds from an insurance recovery and sale of property, plant and equipment	3	25
Net proceeds from corporate-owned life insurance policies	0	21
Net cash used in acquisitions	0	(11)
Finance receivables repaid	0	0
Finance receivables originated	0	0
Other investing activities, net	0	0
Net cash provided by (used in) investing activities	(163)	(116)
Cash flows from financing activities
Decrease in short-term debt	0	(2)
Net proceeds from long-term debt	0	1,137
Proceeds from borrowings against corporate-owned life insurance policies	0	377
Payment on borrowings against corporate-owned life insurance policies	0	(15)
Principal payments on long-term debt and nonrecourse debt	(522)	(195)
Purchases of Textron common stock	(586)	(54)
Dividends paid	(14)	(14)
Proceeds from options exercised	105	16
Other financing activities, net	(2)	(14)
Net cash provided by (used in) financing activities	(1,019)	1,236
Effect of exchange rate changes on cash and equivalents	(6)	(2)
Net increase (decrease) in cash and equivalents	(177)	1,337
Cash and equivalents at beginning of period	2,146	1,181
Cash and equivalents at end of period	1,969	2,518
Finance group
Cash flows from operating activities
Income from continuing operations	3	6
Non-cash items:
Depreciation and amortization	8	4
Gain on business disposition	0	0
Deferred income taxes	(2)	(1)
Asset impairments and TRU inventory charge	0	0
Other, net	(8)	7
Changes in assets and liabilities:
Accounts receivable, net	0	0
Inventories	0	0
Other assets	(1)	0
Accounts payable	0	0
Other liabilities	0	(6)
Income taxes, net	10	(5)
Pension, net	0	0
Other operating activities, net	0	0
Net cash provided by operating activities of continuing operations	10	5
Net cash used in operating activities of discontinued operations	0	0
Net cash provided by operating activities	10	5
Cash flows from investing activities
Capital expenditures	0	0
Net proceeds from business disposition	0	0
Proceeds from an insurance recovery and sale of property, plant and equipment	0	0
Net proceeds from corporate-owned life insurance policies	0	0
Net cash used in acquisitions	0	0
Finance receivables repaid	205	90
Finance receivables originated	(34)	(94)
Other investing activities, net	17	3
Net cash provided by (used in) investing activities	188	(1)
Cash flows from financing activities
Decrease in short-term debt	0	0
Net proceeds from long-term debt	0	0
Proceeds from borrowings against corporate-owned life insurance policies	0	0
Payment on borrowings against corporate-owned life insurance policies	0	0
Principal payments on long-term debt and nonrecourse debt	(93)	(40)
Purchases of Textron common stock	0	0
Dividends paid	0	0
Proceeds from options exercised	0	0
Other financing activities, net	0	12
Net cash provided by (used in) financing activities	(93)	(28)
Effect of exchange rate changes on cash and equivalents	0	0
Net increase (decrease) in cash and equivalents	105	(24)
Cash and equivalents at beginning of period	108	176
Cash and equivalents at end of period	$ 213	$ 152